Adjuvant Therapy for Esophageal Squamous Cell Carcinoma

Abstract

Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise re-view of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.

Keywords

• adjuvant therapy
• esophageal neoplasms
• neoadjuvant therapy
• immuno-therapy